It therefore, appears unclear whether the HCC disease state, liver fibrosis, or a combination of the two contribute to elevated tissue ATX mRNA expression and serum/plasma ATX levels in patients with combinations of liver disease, liver fibrosis, and HCC. This evidence concerns the gene ENPP2 and liver disorder.